{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:59Z","timestamp":1780718519895,"version":"3.54.1"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,6,1]]},"DOI":"10.2169\/internalmedicine.5925-25","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:08:35Z","timestamp":1760566115000},"page":"1560-1565","source":"Crossref","is-referenced-by-count":0,"title":["Microscopic Polyangiitis with Alveolar Hemorrhage Complicated by Myasthenia Gravis"],"prefix":"10.2169","volume":"65","author":[{"given":"Eiji","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Ohta Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Sumichika","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ohta Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Imaizumi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ohta Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ohta Nishinouchi Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11, 2013.","DOI":"10.1007\/s10157-013-0869-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Stone JH, Vasculitides C. The antineutrophil cytoplasmic antibody-associated vasculitides. Wegener's granulomatosis, microscopic polyangiitis, and the Churg-Strauss syndrome. In: Primer on the Rheumatic Diseases. 13th ed. Klippel JH, Stone JH, Crofford LJ, White PH, Eds. Springer, New York, 2008: 416-426.","DOI":"10.1007\/978-0-387-68566-3_53"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Kronbichler A, Bajiema IM, Bruchfeld A, Mastroianni Kirsztajn G, Stone JH. Diagnosis and management of ANCA-associated vasculitis. Lancet 403: 683-698, 2024.","DOI":"10.1016\/S0140-6736(23)01736-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kallenberg CGM. Pathogenesis of ANCA-associated vasculitides. Ann Rheum Dis 70 (Suppl 1): I59-I63, 2011.","DOI":"10.1136\/ard.2010.138024"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis. Nat Rev Dis Primers 5: 30, 2019.","DOI":"10.1038\/s41572-019-0079-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bixio R, Bertelle D, Pistillo F, et al. Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic potions. Clin Rheumatol 41: 1247-1254, 2022.","DOI":"10.1007\/s10067-022-06062-w"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Edrees A. Myasthenia gravis in a patient with systemic lupus erythematosus: a case report and review of the literature. J Rheum Dis Treat 8: 95, 2022.","DOI":"10.23937\/2469-5726\/1510095"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kanazawa M, Shimohata T, Tanaka K, Nishizawa M. Clinical features of patients with myasthenia gravis associated with autoimmune disease. Eur J Neurol 14: 1403-1404, 2007.","DOI":"10.1111\/j.1468-1331.2007.01978.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gilhus NE. Myasthenia gravis. N Engl J Med 375: 2570-2581, 2016.","DOI":"10.1056\/NEJMra1602678"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Niiyama S, Amoh Y, Suzuki K, Wada T, Katsuoka K. Efficacy of tacrolimus against Churg-Strauss syndrome in a patient with myasthenia gravis. Rheumatol Int 30: 847-848, 2010.","DOI":"10.1007\/s00296-009-1039-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Uchi T, Konno S, Kihara H, et al. Myasthenia gravis complicated by eosinophilic granulomatosis with polyangiitis: a case report. Case Rep Neurol 14: 314-319, 2022.","DOI":"10.1159\/000525702"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sato D, Nishiguchi S, Yamamoto D, et al. A contemporaneous onset of eoshinophilic granulomatosis with polyangiitis and myasthenia gravis: a case report. Intern Med 24: 786-789, 2025.","DOI":"10.2169\/internalmedicine.2872-23"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Watts R, Lane S, Hanslik T, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66: 222-227, 2007.","DOI":"10.1136\/ard.2006.054593"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Suppiah R, Robson JC, Grayson PC, et al.; DCVAS Study Group. 2022 American College of Rheumatology\/European Alliance of Association for Rheumatology Classification Criteria for Microscopic Polyangiitis. Arthritis Rheumatol 74: 400-406, 2022.","DOI":"10.1002\/art.41983"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Bae JS, Go SM, Kim BJ. Clinical predictors of steroid-induced exacerbation in myasthenia gravis. J Clin Neurosci 13: 1006-1010, 2006.","DOI":"10.1016\/j.jocn.2005.12.041"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hellmich B, Sanchez-Alamo B, Schirmer JH, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis 83: 30-47, 2024.","DOI":"10.1136\/ard-2024-225606"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Manabe A, Kadoba K, Hiwa R, et al. Risk factors for serious infections and infection-related mortality in patients with microscopic polyangiitis: multicentre REVEAL cohort study. Mod Rheumatol 34: 1185-1193, 2024.","DOI":"10.1093\/mr\/roae024"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Rutgers A, Slot M, van Paassen P, et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCA in crescentic glomerulonephritis. Am J Kidney Dis 46: 253-262, 2005.","DOI":"10.1053\/j.ajkd.2005.05.003"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin Am Soc Nephrol 12: 1162-1172, 2017.","DOI":"10.2215\/CJN.01380217"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yamaguchi M, Sugiyama H, Nobata H, et al. Lymphopenia is a risk factor for severe infections in older patients with microscopic polyangiitis: a retrospective cohort study in Japan. Rheumatol Adv Pract 7: rkad073, 2023.","DOI":"10.1093\/rap\/rkad073"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nakazawa D, Masuda S, Tomaru U, Isizu A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat Rew Rheumatol 15: 91-101, 2019.","DOI":"10.1038\/s41584-018-0145-y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kronbichler A, Lee KH, Denicol\u00f2 S, et al. Immunopathogenesis of ANCA-associated vasculitis. Int J Mol Sci 21: 7319, 2020.","DOI":"10.3390\/ijms21197319"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Miyamoto Y, Hirayama K, Maruyama H, et al. Microscopic polyangiitis associated with thymic tumor: a case report and review of the literature. BMC Nephrol 20: 123, 2019.","DOI":"10.1186\/s12882-019-1319-9"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/11\/65_5925-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:29:04Z","timestamp":1780716544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/11\/65_5925-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5925-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"article-number":"5925-25"}}